Author: thcscout

In this episode of TDR Cannabis in 5, host Shadd Dales combines that release with what DEA revealed last week in its post-hearing brief, together painting a picture he calls truly unprecedented in U.S. cannabis policy.

He breaks down the two takeaways buried inside the testimony that matter most, federal health agencies like HHS and FDA repeatedly affirmed cannabis has a recognized medical use under supervised conditions, and federal scientists directly compared cannabis to other controlled substances, concluding its abuse potential and dependence profile fall well below Schedule I or II drugs.

That connects directly to DEA’s own brief, which stated plainly that marijuana doesn’t meet the criteria for Schedule I, citing more than 30,000 practitioners treating over six million patients across 43 jurisdictions, and directly rebutting the opposition’s arguments point by point.

There’s also a breakdown of what happens next procedurally, Judge Derek Julius now drafts his Recommended Decision with no public timeline attached, followed by an exceptions period and a fixed 30-day Final Order window that can’t be shortened.

The outcome isn’t decided yet, but historically, DEA has been the agency resisting cannabis reform, and now it’s the agency arguing the science supports it.

A clear-eyed look at where rescheduling actually stands right now.

00:00:00 — DEA Rescheduling Transcript Released
00:00:58 — Federal Health Agencies Back Medical Use
00:02:07 — Cannabis Shows Lower Abuse Potential
00:02:48 — DEA Says Cannabis Fails Schedule I Test
00:03:45 — DEA Pushes Back on Opposition
00:04:43 — What Happens Next?

#TDRCannabisIn5 #CannabisRescheduling #DEA #ScheduleIII #DerekJulius #CannabisPolicy #CannabisNews #FederalCannabisPolicy #MedicalCannabis #CannabisLaw

Want to see more Cannabis Reform?
🎬 https://youtu.be/NXBL3SwJ6YE
🎬 https://youtu.be/A0MpYjuRSHU
🎬 https://youtu.be/y39DxV-C8Ro
🎬 https://youtu.be/d-MzQ61mj0E

Want to stay updated on Cannabis, Small Cap, AI, and Crypto?
Subscribe to our Daily Baked newsletter:
https://newsletter.thedalesreport.com/subscribe

Find us on social media and podcast platforms:
✅ Facebook: https://www.facebook.com/TheDalesReport
✅ Twitter: https://twitter.com/TheDalesReport
✅ Instagram: https://www.instagram.com/dalesreport
✅ LinkedIn: https://www.linkedin.com/company/the-dales-report/

Apple Podcasts: https://tinyurl.com/TDRTradetoBlackonApplePodcasts
Spotify: https://tinyurl.com/TDRTradeToBlackonSpotify
Website: https://thedalesreport.com/

For copyright matters, contact:
[email protected]

Podcast Disclaimer (Financial Interests)

The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.

The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.

By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.
Full Disclosures: https://thedalesreport.com/website-terms-of-use/